These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 6498779)

  • 1. Factors related to patient delay in seeking medical attention for cutaneous malignant melanoma.
    Temoshok L; DiClemente RJ; Sweet DM; Blois MS; Sagebiel RW
    Cancer; 1984 Dec; 54(12):3048-53. PubMed ID: 6498779
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biopsychosocial studies on cutaneous malignant melanoma: psychosocial factors associated with prognostic indicators, progression, psychophysiology and tumor-host response.
    Temoshok L
    Soc Sci Med; 1985; 20(8):833-40. PubMed ID: 4001992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patient knowledge, awareness, and delay in seeking medical attention for malignant melanoma.
    Oliveria SA; Christos PJ; Halpern AC; Fine JA; Barnhill RL; Berwick M
    J Clin Epidemiol; 1999 Nov; 52(11):1111-6. PubMed ID: 10527006
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Delay in the diagnosis of cutaneous melanoma: an analysis of 233 patients.
    Schmid-Wendtner MH; Baumert J; Stange J; Volkenandt M
    Melanoma Res; 2002 Aug; 12(4):389-94. PubMed ID: 12170189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship of psychosocial factors to prognostic indicators in cutaneous malignant melanoma.
    Temoshok L; Heller BW; Sagebiel RW; Blois MS; Sweet DM; DiClemente RJ; Gold ML
    J Psychosom Res; 1985; 29(2):139-53. PubMed ID: 4009515
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Epidemiology and prognostic factors in cutaneous malignant melanoma].
    Milo Y; Tamir G; Robinpour M; Sulkes J; Rotem A; Schachter J; Hauben DJ
    Harefuah; 1995 Jun; 128(12):745-51, 824. PubMed ID: 7557679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with a high tumour thickness in patients with melanoma.
    Baumert J; Plewig G; Volkenandt M; Schmid-Wendtner MH
    Br J Dermatol; 2007 May; 156(5):938-44. PubMed ID: 17381454
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Delay in the diagnosis of cutaneous malignant melanoma. A prospective study in 250 patients.
    Krige JE; Isaacs S; Hudson DA; King HS; Strover RM; Johnson CA
    Cancer; 1991 Nov; 68(9):2064-8. PubMed ID: 1913555
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Awareness and early detection of cutaneous melanoma: an analysis of factors related to delay in treatment.
    Blum A; Brand CU; Ellwanger U; Schlagenhauff B; Stroebel W; Rassner G; Garbe C
    Br J Dermatol; 1999 Nov; 141(5):783-7. PubMed ID: 10583157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic subclassifications of T1 cutaneous melanomas based on ulceration, tumour thickness and Clark's level of invasion: results of a population-based study from the Swedish Melanoma Register.
    Lyth J; Hansson J; Ingvar C; Månsson-Brahme E; Naredi P; Stierner U; Wagenius G; Lindholm C;
    Br J Dermatol; 2013 Apr; 168(4):779-86. PubMed ID: 23066913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Factors of delay in the diagnosis of melanoma.
    Betti R; Vergani R; Tolomio E; Santambrogio R; Crosti C
    Eur J Dermatol; 2003; 13(2):183-8. PubMed ID: 12695136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delays in diagnosis and melanoma prognosis (II): the role of doctors.
    Richard MA; Grob JJ; Avril MF; Delaunay M; Gouvernet J; Wolkenstein P; Souteyrand P; Dreno B; Bonerandi JJ; Dalac S; Machet L; Guillaume JC; Chevrant-Breton J; Vilmer C; Aubin F; Guillot B; Beylot-Barry M; Lok C; Raison-Peyron N; Chemaly P
    Int J Cancer; 2000 May; 89(3):280-5. PubMed ID: 10861505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Delays in diagnosis and melanoma prognosis (I): the role of patients.
    Richard MA; Grob JJ; Avril MF; Delaunay M; Gouvernet J; Wolkenstein P; Souteyrand P; Dreno B; Bonerandi JJ; Dalac S; Machet L; Guillaume JC; Chevrant-Breton J; Vilmer C; Aubin F; Guillot B; Beylot-Barry M; Lok C; Raison-Peyron N; Chemaly P
    Int J Cancer; 2000 May; 89(3):271-9. PubMed ID: 10861504
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein D expression in cutaneous malignant melanoma.
    Miranda E; Vizoso F; Martín A; Quintela I; Corte MD; Seguí ME; Ordiz I; Merino AM
    J Surg Oncol; 2003 Jun; 83(2):99-105. PubMed ID: 12772203
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Independent prognostic importance of vascular invasion in nodular melanomas.
    Straume O; Akslen LA
    Cancer; 1996 Sep; 78(6):1211-9. PubMed ID: 8826942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Unusual and unknown aspect of cutaneous malignant melanoma: minimal deviation malignant melanoma. Retrospective study of 45 cases].
    Mérot Y; Mihm MC
    Ann Dermatol Venereol; 1985; 112(4):325-36. PubMed ID: 4026131
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Depth of invasion and tumor thickness in primary cutaneous malignant melanoma. A study of 2012 cases.
    Søndergaard K
    Acta Pathol Microbiol Immunol Scand A; 1985 Mar; 93(2):49-55. PubMed ID: 3984735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cutaneous malignant melanoma in southern Sweden 1965, 1975, and 1985. Prognostic factors and histologic correlations.
    Måsbäck A; Westerdahl J; Ingvar C; Olsson H; Jonsson N
    Cancer; 1997 Jan; 79(2):275-83. PubMed ID: 9010101
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Malignant melanoma in the elderly.
    Cohen HJ; Cox E; Manton K; Woodbury M
    J Clin Oncol; 1987 Jan; 5(1):100-6. PubMed ID: 3806154
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic and psychosocial factors related to delay behavior in patients with cutaneous malignant melanoma.
    Temoshok L; DiClemente RJ; Sweet DM; Blois MS; Sagebiel RW
    Prog Clin Biol Res; 1984; 156():169-79. PubMed ID: 6473424
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.